AUG 19, 2021 8:00 PM PDT

Can drugs increase sociability after pediatric brain injury?

WRITTEN BY: J. Bryce Ortiz

Traumatic brain injuries (TBIs) are a leading cause of death and disability in children. In the United States, close to 600,000 children visit an emergency department ever year due to a brain injury and, of these, 62,000 children require hospitalization. An injury to the brain in early life can lead to a vast array of effects. These changes often differ from adults who suffer from a brain injury because the pediatric brain is still developing. In fact, many TBI-related deficits can be hidden and may manifest over time. 

One deficit that commonly results from a pediatric brain injury are social behavior impairments. Social behavior or social cognition, is the ability to perceive, understand, and act on social cues from other individuals. Social behavioral impairments are a common and significant challenge for pediatric brain injury survivors, their families, and society as a whole. In a recent review, two brain injury researchers argue that social behavioral impairments in children that arise after a brain injury can potentially be treated with drug therapies. 

The authors begin the article by outlining preclinical work that aims to understand the effects of brain injury in children. They state that animal models of pediatric brain injury demonstrate good face validity and include similar symptoms as to what is observed in humans. Along these lines they outline several measures of social behavior that can be modeled in the preclinical laboratory. These tests provide a good measure of sociability that can be easily tested in laboratory animals. 

Because of this, the authors have outlined a list of compounds and targeted treatments that might be used to treat traumatic brain injury and improve sociability in children. Testing these compounds in laboratory animals to understand if they improve sociability would be a good first step in treating social behavioral disorders and a way to discover and design drugs that can be used in humans and improve the lives of pediatric brain injury survivors. 

Sources: Brain Injury Association of AmericaAmerican Speech-Language-Hearing AssociationFrontiers in Neurology: Neurotrauma

About the Author
  • Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 12, 2021
Cannabis Sciences
Medicinal Cannabis May Help with Stuttering
AUG 12, 2021
Medicinal Cannabis May Help with Stuttering
Medicinal cannabis reduced treatment-resistant stuttering in a 20-year-old male patient. The case study was published in ...
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 20, 2021
Drug Discovery & Development
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
AUG 20, 2021
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
Researchers have identified two antibodies that can protect animals from diseases caused by alphaviruses, which are RNA ...
AUG 24, 2021
Drug Discovery & Development
A comparison of drugs for relapsing-remitting multiple sclerosis.
AUG 24, 2021
A comparison of drugs for relapsing-remitting multiple sclerosis.
     Multiple sclerosis (MS) is a rare and unpredictable autoimmune disease in which the body’s inn ...
SEP 28, 2021
Drug Discovery & Development
The FDA approves drug to treat a bad cholesterol in children
SEP 28, 2021
The FDA approves drug to treat a bad cholesterol in children
Familial hypercholesterolemia (FH) is a genetic disorder that afflicts approximately 1 in 250 people. Interestingly, whi ...
Loading Comments...